Interestingly, HMGB1 is regulated by both JNK1/2-ATF2-dependent signaling at the transcriptional level, and by the miR-200 family, at the post-transcriptional level in nonalcoholic steatohepatitis (NASH)13. Here, HMGB1 is linked to metabolic dysfunction-associated steatohepatitis.